Regulatory & Legal

In a major step to prevent future health crises, the CDC has selected Cepheid to help create rapid diagnostic tests for emerging threats before they spread.

AI firm Docebo's $60M share buyback is complicated by its majority owner's surprise move and new debt, sparking questions about its strategy.

Hyliion's fuel-agnostic generator runs on diesel, meeting tough emission rules without add-ons and unlocking resilient power for defense and data centers.

Riding a wave of innovation and strategic shifts, the cruise wellness leader posts record earnings and projects over $1B in 2026 revenue.

A new biotech emerges with massive funding and a next-gen 'shuttle' to deliver safer, more effective Alzheimer's therapies directly to the brain.

The produce giant reported strong 2025 earnings after divesting its vegetable unit, reducing debt, and investing in new high-growth areas like avocado oil.

Polestar unveils a bold plan to launch four new models by 2028, but can the EV maker overcome financial hurdles and intense market competition?

Auddia Inc. announces a merger with its CEO's holdings, creating a new $250M entity, McCarthy Finney, and leaving current shareholders with a 20% stake.

A new report reveals retail traders are abandoning anonymous forums for platforms with audited data, professionalizing the meme stock era for good.

The specialty minerals giant reports solid Q4 earnings while announcing a major strategic shift away from industrial ventures to focus on high-growth areas.

The online gaming operator smashed 2025 expectations with record revenue and profits, signaling strong confidence in its casino-first and international strategy.

After a regulatory clash forced its exit, crypto giant Nexo is returning to the US by leveraging Bakkt's licensed infrastructure, setting a new precedent.

Universal Health Services will present at three key March conferences, facing investors with robust profits but also cautious analyst outlooks and industry challenges.

As Jazz Pharmaceuticals preps for key investor talks, all eyes are on its blockbuster pipeline, revenue growth, and strategy to fend off competition.

With a $180M commitment, new specialty carrier Pinion Insurance aims to revolutionize the MGA market with its proprietary technology and deep expertise.

With a $50.1M financing led by top investors, Coherus solidifies its strategic pivot from biosimilars to a pure-play oncology powerhouse.

Facing massive revenue declines and a shrinking coach network due to GLP-1 drugs, Medifast bets its future on a risky pivot from weight loss to metabolic health.

Nearly 500 Teamsters at MarinHealth will strike over a proposal to add up to $1,000 in monthly health costs, escalating a year-long contract battle.

Iridium heads to key investor conferences with a message of long-term growth in PNT and direct-to-device, despite a cautious 2026 financial outlook.

One of America's largest credit unions opens in St. Thomas, promising new jobs and financial options in the U.S. Virgin Islands' unique economic climate.